New Antivirals Show Potential Against COVID-19

Researchers from Columbia Engineering, Fiocruz's Center for Technological Development in Health and the Oswaldo Cruz Institute in Brazil, Memorial Sloan Kettering Cancer Center, and Rockefeller University recently reported that, by combining inhibitors of polymerases and exonucleases -- enzymes that allow SARS-CoV-2 to reproduce -- they were able to reduce SARS-CoV-2 replication 10 times more than when using just the polymerase inhibitors.

Ready to begin?

Go to the student dashboard.

Not sure what courses you need?

Browse our course catalog!